Human Papillomavirus (HPV) is a diverse group of DNA viruses that infect the epithelial cells of the skin and mucous membranes. With over 200 identified types, HPVs are classified into low-risk and high-risk types based on their association with cancer. Low-risk HPV types, such as HPV 6 and 11, commonly cause Genital Warts and benign lesions. In contrast, high-risk types, notably HPV 16 and 18, are strongly linked to the development of various cancers, including cervical, anal, penile, vaginal, and oropharyngeal cancers. Cervical cancer, in particular, is strongly associated with persistent infection by high-risk HPV types. HPV is a sexually transmitted infection, and certain behaviors, such as early age at first sexual activity, multiple sexual partners, and immunosuppression, increase the risk of acquiring and maintaining HPV infections. Preventive measures for HPV-related cancers include vaccination and cervical cancer screening. HPV vaccines, such as Gardasil and Cervarix, target high-risk HPV types and have demonstrated efficacy in preventing infections and associated cancers. Cervical cancer screening methods, including Pap smears and HPV testing, aim to detect precancerous lesions for early intervention. Global efforts to increase HPV vaccination coverage and improve screening programs are critical for reducing the burden of HPV-related cancers. Education about the importance of vaccination, safe sexual practices, and regular screening contributes to the comprehensive approach needed to control HPV infections and associated diseases.